Hollis Dsouza

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Cancer · 2019 · 130 citations

Medicine, Oncology, Radiation Oncology +11

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Vijay Patil, Vanita Noronha, Sachin Dhumal et al. · The Lancet Global Health · 2020 · 102 citations · Full text

Medicine, Oncology, Chemotherapy +11

Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 76 citations

Medicine, Oncology, Pharmacology +17

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer

Vanita Noronha, Vijay Patil, Amit Joshi et al. · Oncotarget · 2020 · 24 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer

Amit Joshi, Vijay Patil, Vanita Noronha et al. · Oral Oncology · 2017 · 15 citations

Medicine, Oncology, Pharmacology +6